Quality Antibody for Assessing CD4 Expression on Peripheral CD4+ T Cells by Flow Cytometry

Division of BioMedical Sciences, Faculty of Medicine
Memorial University of Newfoundland
Research Assistant

Overall

Quality of Results

Ease-of-Optimization

What do these ratings mean?
Write a Review

Company:

eBioscience (Thermo Fisher Scientific - Invitrogen)

Product Name:

CD4 Monoclonal Antibody (RPA-T4), PerCP-Cyanine5.5, eBioscience™

Catalog Number:

45-0049-42

Clone Number:

RPA-T4

Our research involves the study of immune cell phenotypes in different disease states with a focus on viral infection. This antibody was used to assess the purity of CD4+ T cells that were positively selected from total peripheral blood mononuclear cells.

Experimental Design and Results Summary

Applications

Flow Cytometry

Sample

Purified CD4+ T cells from human PBMC by magnetic bead-based positive selection

Primary Incubation

2.0x10^5 cells were stained with the manufacturer's recommended volume of antibody in a total staining volume of 100ul autoMACS running buffer (Miltenyi Biotec) for 30 minutes on ice in the dark.

Blocking Agent

10 min on ice with human Fc receptor blocking reagent (Miltenyi Biotec) prior to primary incubation with fluorochrome-labelled antibody

Secondary Incubation

N/A

Tertiary Incubation

N/A

Detection

Becton Dickinson FACSCalibur flow cytometer

Results Summary

This antibody resulted in a distinct population of CD4+ cells (unfilled histogram) that are easily distinguished from CD4+ cells stained with a matched isotype control antibody (filled histogram). >95% of purified CD4+ T cells stained for CD4.

DOI or PMID #

10.1186/s12865-015-0113-0

Additional Notes

N/A

Related Categories

Image Gallery

Summary

The Good

Bright staining. Little optimization required other than initial titrating.

The Bad

None

The Bottom Line

Recommended for identifying CD4+ cells in PBMC samples or purified T cell preparations by flow cytometry.

Share your experience with other scientists. Write a Review! »

Join the discussion